Articles

We are happy to share that on Friday, just 11 days after the launch, we completed the placement of the first tranche of corporate bonds issued by Vardanants Center for Innovative Medicine (Vardanants CIM).

The entire 1 billion AMD issuance was fully subscribed—a strong mix of both retail investors (ranging from 100,000 to 100 million AMD) and institutional investors, including two pension fund managers, C-Quadrat Ampega and Amundi-ACBA, who collectively acquired approximately one-third of the total volume.

The issuance and distribution of bonds were carried out in cooperation with Converse Bank, ensuring a seamless and professional organization of the process.

Congratulations to our team, partners, customers, and investors on this remarkable milestone! This placement is a powerful validation of the trust in our brand and the market’s confidence in our long-term vision and strategic direction.

We remain committed to investing in the development of the Armenian healthcare sector, driving the adoption of modern technologies and innovative approaches to improve health outcomes and the wellbeing of our fellow citizens.

Stay tuned—there’s more to come.